Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	heart development	TRAF3IP1 PKD1L1 PTPRJ ALPK3 HECTD1 KDM6A NOTCH1 CACNA1C HSPG2 RPGRIP1L SYNE1 CASP8 PCDHA10 NR3C1 CSRP3 C2CD3 VWA5A VCAN FOXP1 ALPK2 PCNT	7.10e-06	757	190	21	GO:0007507
GeneOntologyBiologicalProcess	circulatory system development	MYLK TRAF3IP1 PKD1L1 PTPRJ ALPK3 SERPINF2 HECTD1 KDM6A NOTCH1 CACNA1C HSPG2 RPGRIP1L COL15A1 SYNE1 CASP8 PCDHA10 APOB SH2D2A NR3C1 NXN CSRP3 C2CD3 EGF VWA5A VCAN CSPG4 FOXP1 SLC2A12 ALPK2 PCNT	2.25e-05	1442	190	30	GO:0072359
GeneOntologyBiologicalProcess	protein localization to organelle	WBP2 NUP50 SIX4 CEP68 BNIP3L MAVS BRCA2 NOTCH1 SEC16B RANBP2 AKAP5 KALRN SYNE1 SGTA CEP192 COX18 APLF CSRP3 PIKFYVE VPS13D C2CD3 EGF TRAM1 CEP250 CDH1	2.46e-05	1091	190	25	GO:0033365
GeneOntologyCellularComponent	collagen-containing extracellular matrix	COL6A5 COL24A1 FCN2 SERPINF2 NPHS1 FLG HSPG2 COL15A1 LAMA5 FREM3 HMCN1 VWA5A VCAN CSPG4 HCFC1 SERPINA5	3.74e-05	530	194	16	GO:0062023
GeneOntologyCellularComponent	pericentriolar material	CEP85L CEP192 AKAP9 PCNT	1.24e-04	28	194	4	GO:0000242
GeneOntologyCellularComponent	extracellular matrix	COL6A5 COL24A1 FCN2 SERPINF2 GP1BA NPHS1 FLG HSPG2 COL15A1 LAMA5 FREM3 HMCN1 VWA5A VCAN CSPG4 HCFC1 SERPINA5	1.39e-04	656	194	17	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	COL6A5 COL24A1 FCN2 SERPINF2 GP1BA NPHS1 FLG HSPG2 COL15A1 LAMA5 FREM3 HMCN1 VWA5A VCAN CSPG4 HCFC1 SERPINA5	1.44e-04	658	194	17	GO:0030312
GeneOntologyCellularComponent	collagen trimer	COL6A5 COL24A1 FCN2 C1QTNF2 COL15A1 MSR1	1.70e-04	88	194	6	GO:0005581
GeneOntologyCellularComponent	centrosome	TRAF3IP1 CEP85L KIZ BIRC6 CEP68 BRCA2 CAMSAP2 DYNC1I2 RPGRIP1L ARFGEF2 CEP192 NR3C1 TUBGCP6 C2CD3 AKAP9 CEP250 CEP295 PCNT	3.13e-04	770	194	18	GO:0005813
GeneOntologyCellularComponent	membrane raft	FCER1A KCND2 STOML2 VDAC2 CACNA1C AKAP5 PIKFYVE PPP2CA CD4 MDGA1 CDH1	5.93e-04	362	194	11	GO:0045121
GeneOntologyCellularComponent	membrane microdomain	FCER1A KCND2 STOML2 VDAC2 CACNA1C AKAP5 PIKFYVE PPP2CA CD4 MDGA1 CDH1	6.20e-04	364	194	11	GO:0098857
Domain	Laminin_G	COL24A1 HSPG2 COL15A1 TSPEAR LAMA5 CRB1 CSPG4 SLIT1	1.33e-07	58	192	8	IPR001791
Domain	LamG	HSPG2 COL15A1 TSPEAR LAMA5 CRB1 CSPG4 SLIT1	3.02e-07	44	192	7	SM00282
Domain	LAM_G_DOMAIN	COL24A1 HSPG2 LAMA5 CRB1 CSPG4 SLIT1	2.29e-06	38	192	6	PS50025
Domain	Laminin_G_2	COL24A1 HSPG2 LAMA5 CRB1 CSPG4 SLIT1	3.13e-06	40	192	6	PF02210
Domain	-	MYLK NXPE4 FCER1A PTPRJ ALPK3 IGSF9 CAMTA1 PLXNA1 NPHS1 HSPG2 KALRN CD4 HMCN1 VCAN RIMBP2 TGM7 SIGLEC11 MDGA1 HCFC1 ALPK2 PDCD1LG2	4.95e-06	663	192	21	2.60.40.10
Domain	IGc2	MYLK FCER1A ALPK3 IGSF9 NPHS1 HSPG2 KALRN CD4 HMCN1 SIGLEC11 MDGA1 ALPK2	5.98e-06	235	192	12	SM00408
Domain	Ig_sub2	MYLK FCER1A ALPK3 IGSF9 NPHS1 HSPG2 KALRN CD4 HMCN1 SIGLEC11 MDGA1 ALPK2	5.98e-06	235	192	12	IPR003598
Domain	Ig-like_fold	MYLK NXPE4 FCER1A PTPRJ ALPK3 IGSF9 CAMTA1 PLXNA1 NPHS1 HSPG2 KALRN CD4 HMCN1 VCAN RIMBP2 TGM7 SIGLEC11 MDGA1 HCFC1 ALPK2 PDCD1LG2	1.29e-05	706	192	21	IPR013783
Domain	Ig_I-set	MYLK ALPK3 IGSF9 NPHS1 HSPG2 KALRN HMCN1 SIGLEC11 MDGA1 ALPK2	2.80e-05	190	192	10	IPR013098
Domain	I-set	MYLK ALPK3 IGSF9 NPHS1 HSPG2 KALRN HMCN1 SIGLEC11 MDGA1 ALPK2	2.80e-05	190	192	10	PF07679
Domain	ConA-like_dom	COL24A1 HERC1 HSPG2 COL15A1 TSPEAR LAMA5 CRB1 CSPG4 SLIT1 MDGA1	9.25e-05	219	192	10	IPR013320
Domain	PACT_coil_coil	AKAP9 PCNT	1.05e-04	2	192	2	PF10495
Domain	PACT_domain	AKAP9 PCNT	1.05e-04	2	192	2	IPR019528
Domain	IG	MYLK FCER1A ALPK3 IGSF9 NPHS1 HSPG2 KALRN CD4 HMCN1 VCAN SIGLEC11 MDGA1 ALPK2 PDCD1LG2	1.21e-04	421	192	14	SM00409
Domain	Ig_sub	MYLK FCER1A ALPK3 IGSF9 NPHS1 HSPG2 KALRN CD4 HMCN1 VCAN SIGLEC11 MDGA1 ALPK2 PDCD1LG2	1.21e-04	421	192	14	IPR003599
Domain	Growth_fac_rcpt_	BRINP3 NOTCH1 HSPG2 LAMA5 CRB1 EGF HMCN1 SLIT1	2.14e-04	156	192	8	IPR009030
Domain	Collagen	COL6A5 COL24A1 FCN2 C1QTNF2 COL15A1 MSR1	2.43e-04	85	192	6	IPR008160
Domain	Collagen	COL6A5 COL24A1 FCN2 C1QTNF2 COL15A1 MSR1	2.43e-04	85	192	6	PF01391
Domain	EGF_CA	NOTCH1 HSPG2 CRB1 EGF HMCN1 VCAN SLIT1	2.69e-04	122	192	7	SM00179
Domain	EGF-like_Ca-bd_dom	NOTCH1 HSPG2 CRB1 EGF HMCN1 VCAN SLIT1	2.97e-04	124	192	7	IPR001881
Domain	EGF	NOTCH1 HSPG2 CRB1 EGF HMCN1 VCAN SLIT1	3.28e-04	126	192	7	PF00008
Domain	-	COL24A1 HSPG2 LAMA5 CRB1 CSPG4 SLIT1	4.44e-04	95	192	6	2.60.120.200
Domain	EGF_Ca-bd_CS	NOTCH1 CRB1 EGF HMCN1 VCAN SLIT1	4.97e-04	97	192	6	IPR018097
Domain	EGF_CA	NOTCH1 CRB1 EGF HMCN1 VCAN SLIT1	5.54e-04	99	192	6	PS01187
Domain	IG_LIKE	MYLK FCER1A ALPK3 IGSF9 NPHS1 HSPG2 KALRN CD4 HMCN1 VCAN SIGLEC11 MDGA1 ALPK2 PDCD1LG2	5.75e-04	491	192	14	PS50835
Domain	VDCC_L_a1su	CACNA1C CACNA1S	6.22e-04	4	192	2	IPR005446
Domain	REJ	PKD1L1 PKD1L2	6.22e-04	4	192	2	PS51111
Domain	REJ_dom	PKD1L1 PKD1L2	6.22e-04	4	192	2	IPR014010
Domain	FN3	MYLK PTPRJ IGSF9 NPHS1 KALRN RIMBP2 MDGA1 HCFC1	6.69e-04	185	192	8	SM00060
Domain	Ig-like_dom	MYLK FCER1A ALPK3 IGSF9 NPHS1 HSPG2 KALRN CD4 HMCN1 VCAN SIGLEC11 MDGA1 ALPK2 PDCD1LG2	7.28e-04	503	192	14	IPR007110
Domain	EGF	BRINP3 NOTCH1 HSPG2 LAMA5 CRB1 EGF HMCN1 VCAN SLIT1	7.48e-04	235	192	9	SM00181
Domain	EGF-type_Asp/Asn_hydroxyl_site	NOTCH1 CRB1 EGF HMCN1 VCAN SLIT1	7.95e-04	106	192	6	IPR000152
Domain	FN3	MYLK PTPRJ IGSF9 NPHS1 KALRN RIMBP2 MDGA1 HCFC1	1.07e-03	199	192	8	PS50853
Domain	FN3_dom	MYLK PTPRJ IGSF9 NPHS1 KALRN RIMBP2 MDGA1 HCFC1	1.47e-03	209	192	8	IPR003961
Domain	Alpha_kinase	ALPK3 ALPK2	1.53e-03	6	192	2	PF02816
Domain	MHCK_EF2_kinase	ALPK3 ALPK2	1.53e-03	6	192	2	IPR004166
Domain	PKD/REJ-like	PKD1L1 PKD1L2	1.53e-03	6	192	2	IPR002859
Domain	ALPHA_KINASE	ALPK3 ALPK2	1.53e-03	6	192	2	PS51158
Domain	Alpha_kinase	ALPK3 ALPK2	1.53e-03	6	192	2	SM00811
Domain	REJ	PKD1L1 PKD1L2	1.53e-03	6	192	2	PF02010
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TTC3 BIRC6 C2CD2L PLEKHG1 XPO6 LRRC56 HERC1 HECTD1 PLXNA1 NOTCH1 HSPG2 KALRN HIP1R ARFGEF2 LMTK2 LAMA5 FRYL CEP192 IDUA PIKFYVE PPP2CB C2CD3 CSPG4 HELZ2 ZNF839 HCFC1 PCNT	1.71e-10	1105	196	27	35748872
Pubmed	Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods.	CEP85L CEP68 DYNC1I2 RPGRIP1L CEP192 TUBGCP6 C2CD3 AKAP9 CEP250 CEP295 PCNT	7.75e-10	146	196	11	21399614
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GPATCH8 C2CD2L PLEKHG1 KIDINS220 NUFIP2 BOD1L1 CAMTA1 CAMSAP2 SYNE1 FRMPD1 CEP192 AKAP9 BAZ2A SLIT1 RIMBP2 PCNT	1.64e-09	407	196	16	12693553
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	COL6A5 COL24A1 SERPINF2 HSPG2 COL15A1 LAMA5 HMCN1 VWA5A VCAN CSPG4 HCFC1	3.22e-09	167	196	11	22159717
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	NUP50 SIX4 BIRC6 PTPRJ NUFIP2 HERC1 KDM6A NOTCH1 STOML2 RANBP2 AKAP5 RPGRIP1L KRT16 PPFIA1 LMTK2 ELP1 CEP192 PPP2CA PPP2CB C2CD3 AKAP9 RAI14 ZKSCAN4 PCNT	6.90e-09	1049	196	24	27880917
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	COL6A5 HSPG2 COL15A1 APOB FREM3 HMCN1 VCAN	7.68e-08	64	196	7	22261194
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	HIVEP1 STAT6 KALRN SYNE1 DNAH2 CDC42EP3 PIKFYVE RAI14 CEP295 HSPA14 TEX28	1.00e-07	233	196	11	37704626
Pubmed	Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence.	HIVEP1 PLEKHG1 KCND2 PKNOX2	3.13e-07	11	196	4	22488850
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	UIMC1 SP3 METTL3 GPATCH8 SIX4 ZNF767P C2CD2L KIDINS220 NUFIP2 CAMSAP2 VDAC2 SEL1L RANBP2 SYNE1 PPFIA1 HIP1R LAMA5 ATAD2 CCNT1 PPP2CA USP10 BAZ2A TRAM1 HELZ2 RAI14 ISG20L2	3.71e-07	1497	196	26	31527615
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	UIMC1 SPAG1 MYLK TTC3 BOD1L1 CAMSAP2 DYNC1I2 CACNA1C FLG RANBP2 AKAP5 KRT16 SYNE1 PPFIA1 DNAH2 APOB PPP2CA PPP2CB C2CD3 SLC25A12 CSPG4 ISG20L2 CEP295 CDH1 PCNT	6.56e-07	1442	196	25	35575683
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	BIRC6 C2CD2L CEP68 XPO6 CAMTA1 PRUNE2 SYNE1 SLIT1 HELZ2 PCNT	6.73e-07	225	196	10	12168954
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL6A5 COL24A1 SERPINF2 HSPG2 COL15A1 LAMA5 HMCN1 VWA5A HCFC1	7.34e-07	175	196	9	28071719
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	GPATCH8 TTC3 ARFIP1 STAT6 ZNF600 RXFP2 BOD1L1 CAMTA1 HERC1 NPAT PPFIA1 FRMPD1 LMTK2 APOB FRYL CEP192 COX18 VCAN CEP295 CDH1 PCNT	9.77e-07	1084	196	21	11544199
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	COL6A5 COL24A1 SERPINF2 HSPG2 COL15A1 LAMA5 VCAN CSPG4	1.06e-06	135	196	8	28675934
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	WBP2 SP3 UBAP2 BNIP3L CAMTA1 NOTCH1 PRUNE2 CACNA1S PKNOX2 MAP4K5 ZKSCAN4 CLSPN PCNT	1.15e-06	430	196	13	35044719
Pubmed	Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis.	PROM1 HSPG2 LAMA5 VCAN CDH1	1.53e-06	35	196	5	18676816
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CEP85L KIZ PKD1L1 PLEKHG1 MAVS BRCA2 ARHGAP29 CAMSAP2 DYNC1I2 RANBP2 RPGRIP1L CASP8 CEP192 C2CD3 CEP250 CEP295 PDZRN3 PCNT	1.86e-06	853	196	18	28718761
Pubmed	Centrosomal proteins CG-NAP and kendrin provide microtubule nucleation sites by anchoring gamma-tubulin ring complex.	DYNC1I2 CEP192 TUBGCP6 AKAP9 CEP250 PCNT	2.04e-06	66	196	6	12221128
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	UIMC1 NUP50 ZNF845 HIVEP1 UBAP2 BRCA2 NUFIP2 BOD1L1 ZCCHC7 VDAC2 NPAT RANBP2 PPIL4 CASP8 CCNT1 BAZ2A SS18L1 ZKSCAN4 HCFC1	2.21e-06	954	196	19	36373674
Pubmed	The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity.	KIZ AKAP9 PCNT	3.48e-06	6	196	3	16980960
Pubmed	Distinct role of protein phosphatase 2A subunit Calpha in the regulation of E-cadherin and beta-catenin during development.	PPP2CA PPP2CB CDH1	3.48e-06	6	196	3	10781942
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	KIZ TTC3 ZNF767P KIDINS220 PTPRJ IGSF9 BOD1L1 CAMTA1 HECTD1 KDM6A PRUNE2 CACNA1C SGTA FRMPD1 FRYL CEP192 NXN CDC42EP3 PKNOX2 USP10 FOXP1 RAI14 ZNF839 PCNT	3.92e-06	1489	196	24	28611215
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	UBAP2 GPATCH8 BIRC6 C2CD2L MAVS NUFIP2 BOD1L1 HECTD1 RPGRIP1L PPFIA1 PIKFYVE EDEM3 CEP295 CLSPN HCFC1 PDZRN3	4.65e-06	733	196	16	34672954
Pubmed	BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer	BRCA2 CASP8 SLC22A18 CDH1	5.43e-06	21	196	4	20301425
Pubmed	Elongator and codon bias regulate protein levels in mammalian peripheral neurons.	BRCA2 ELP1 VCAN	6.07e-06	7	196	3	29497044
Pubmed	Human transcription factor protein interaction networks.	UIMC1 HIVEP1 UBAP2 GPATCH8 SIX4 RNF214 HERC1 KDM6A VDAC2 NPAT FLG HSPG2 TCF12 PPIL4 CEP192 PPP2CA SS18L1 ZNF611 FOXP1 RAI14 ZKSCAN4 KAT14 HCFC1	6.48e-06	1429	196	23	35140242
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	UIMC1 NUP50 UBAP2 ARFIP1 MAVS NUFIP2 BOD1L1 CAMSAP2 VDAC2 RANBP2 NR3C1 CCNT1 PPP2CA USP10 BAZ2A RAI14 HCFC1 PCNT	6.50e-06	934	196	18	33916271
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	UIMC1 NUP50 MAVS BRCA2 NUFIP2 RANBP2 TCF12 NR3C1 CCNT1 USP10 VWA5A HCFC1	9.30e-06	444	196	12	34795231
Pubmed	Mitochondrial antiviral-signalling protein is a client of the BAG6 protein quality control complex.	NUP50 MAVS SGTA HCFC1	9.52e-06	24	196	4	35543156
Pubmed	Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy.	CCNT1 PPP2CA PPP2CB	9.67e-06	8	196	3	35768646
Pubmed	Comparative analysis of the expression of cytokeratins (1, 10, 14, 16, 4), involucrin, filaggrin and e-cadherin in plane warts and epidermodysplasia verruciformis plane wart-type lesions.	FLG KRT16 CDH1	9.67e-06	8	196	3	19515043
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	WBP2 BIRC6 PLEKHG1 HECTD1 NOTCH1 PPFIA1 ELP1 FRYL CEP192 USP10 AKAP9 CEP295	9.72e-06	446	196	12	24255178
Pubmed	Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital.	NR3C1 PPP2CA PPP2CB	1.44e-05	9	196	3	12885400
Pubmed	Spatial centrosome proteome of human neural cells uncovers disease-relevant heterogeneity.	NUP50 CEP68 NUFIP2 CEP192	1.55e-05	27	196	4	35709258
Pubmed	The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion.	DYNC1I2 CEP192 AKAP9 CEP250 PCNT	1.63e-05	56	196	5	11076968
Pubmed	The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation.	DYNC1I2 CEP192 AKAP9 CEP250 PCNT	1.78e-05	57	196	5	16462731
Pubmed	The intracellular NADH level regulates atrophic nonunion pathogenesis through the CtBP2-p300-Runx2 transcriptional complex.	UBAP2 KIZ STOML2 TCF19 FOXP1 HCFC1 MMUT	1.86e-05	144	196	7	30585266
Pubmed	Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation.	DYNC1I2 CEP192 AKAP9 CEP250 PCNT	1.94e-05	58	196	5	12852856
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	KIZ CEP192 C2CD3 CEP250 CEP295 PCNT	2.41e-05	101	196	6	24613305
Pubmed	EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.	USP25 HERC1 SEL1L SGTA ATL3 EDEM3 USP10	2.42e-05	150	196	7	32423001
Pubmed	Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function.	DYNC1I2 CEP192 AKAP9 CEP250 PCNT	2.49e-05	61	196	5	7790358
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	TRAF3IP1 KALRN SYNE1 FRYL ZNF17 AKAP9 CEP295	2.52e-05	151	196	7	17043677
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	BIRC6 CEP68 HECTD1 PRUNE2 SEC16B ZNF407 PIKFYVE ZBTB34 VPS13D SS18L1 HELZ2 PDZRN3	2.61e-05	493	196	12	15368895
Pubmed	ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation.	NOTCH1 HSPG2 LAMA5 CDH1	2.73e-05	31	196	4	22274697
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	HIVEP1 BIRC6 BRCA2 NPAT RANBP2 PPFIA1 FOXP1 RAI14 ZKSCAN4 KAT14 PCNT	2.81e-05	418	196	11	34709266
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	HIVEP1 TTC3 BIRC6 HSPG2 RANBP2 TCF12 KALRN SYNE1 ELP1 ZNF407 CSRP3 AKAP9	2.82e-05	497	196	12	23414517
Pubmed	Analysis of axonal regeneration in the central and peripheral nervous systems of the NG2-deficient mouse.	VCAN CSPG4	3.16e-05	2	196	2	17900358
Pubmed	CD148 tyrosine phosphatase promotes cadherin cell adhesion.	PTPRJ CDH1	3.16e-05	2	196	2	25386896
Pubmed	METTL3-mediated Hsa_circ_0000390 downregulation enhances the proliferation, migration, and invasion of colorectal cancer cells by increasing Notch1 expression.	METTL3 NOTCH1	3.16e-05	2	196	2	36600025
Pubmed	Regulation of spindle formation by active mitogen-activated protein kinase and protein phosphatase 2A during mouse oocyte meiosis.	PPP2CA PPP2CB	3.16e-05	2	196	2	11751260
Pubmed	Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.	VCAN CDH1	3.16e-05	2	196	2	23002209
Pubmed	Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels.	CACNA1C AKAP5	3.16e-05	2	196	2	20671242
Pubmed	Coding variants in the PCNT and CEP295 genes contribute to breast cancer risk in Chinese women.	CEP295 PCNT	3.16e-05	2	196	2	34418690
Pubmed	Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.	HSPG2 CSPG4	3.16e-05	2	196	2	29462330
Pubmed	Antiviral activities of ISG20 in positive-strand RNA virus infections.	ISG20 ISG20L2	3.16e-05	2	196	2	21036379
Pubmed	Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.	METTL3 ATAD2	3.16e-05	2	196	2	32044716
Pubmed	Mettl3 deficiency leads to the upregulation of Cav1.2 and increases arrhythmia susceptibility in mice.	METTL3 CACNA1C	3.16e-05	2	196	2	35130614
Pubmed	Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells.	KDM6A CDH1	3.16e-05	2	196	2	26819089
Pubmed	NOTCH1 regulates migration and invasion of skin cancer cells by E-cadherin repression.	NOTCH1 CDH1	3.16e-05	2	196	2	22038626
Pubmed	Mutations in TSPEAR, Encoding a Regulator of Notch Signaling, Affect Tooth and Hair Follicle Morphogenesis.	NOTCH1 TSPEAR	3.16e-05	2	196	2	27736875
Pubmed	AKAP79 modulation of L-type channels involves disruption of intramolecular interactions in the CaV1.2 subunit.	CACNA1C AKAP5	3.16e-05	2	196	2	22677788
Pubmed	Autophagy is involved in mouse kidney development and podocyte differentiation regulated by Notch signalling.	NOTCH1 NPHS1	3.16e-05	2	196	2	28158917
Pubmed	The Prognostic Significance of Histone Demethylase UTX in Esophageal Squamous Cell Carcinoma.	KDM6A CDH1	3.16e-05	2	196	2	29351209
Pubmed	The role of protein phosphatase 2A catalytic subunit Calpha in embryogenesis: evidence from sequence analysis and localization studies.	PPP2CA PPP2CB	3.16e-05	2	196	2	10543450
Pubmed	Critical role for caspase-8 in epidermal growth factor signaling.	CASP8 EGF	3.16e-05	2	196	2	19470771
Pubmed	Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133.	PROM1 VCAN	3.16e-05	2	196	2	17185982
Pubmed	Estradiol protects dermal hyaluronan/versican matrix during photoaging by release of epidermal growth factor from keratinocytes.	EGF VCAN	3.16e-05	2	196	2	22493503
Pubmed	UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis.	SIX4 KDM6A	3.16e-05	2	196	2	20300060
Pubmed	Restoration of normal L-type Ca2+ channel function during Timothy syndrome by ablation of an anchoring protein.	CACNA1C AKAP5	3.16e-05	2	196	2	21700933
Pubmed	A-kinase anchoring proteins contribute to loss of E-cadherin and bronchial epithelial barrier by cigarette smoke.	AKAP9 CDH1	3.16e-05	2	196	2	24452374
Pubmed	Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes.	PPP2CA PPP2CB	3.16e-05	2	196	2	1846293
Pubmed	Endogenous cardiac Ca2+ channels do not overcome the E-C coupling defect in immortalized dysgenic muscle cells: evidence for a missing link.	CACNA1C CACNA1S	3.16e-05	2	196	2	7635187
Pubmed	PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte.	PPP2CA PPP2CB	3.16e-05	2	196	2	27096707
Pubmed	Protein phosphatase 2A effectively modulates basal L-type Ca(2+) current by dephosphorylating Ca(v)1.2 at serine 1866 in mouse cardiac myocytes.	CACNA1C PPP2CA	3.16e-05	2	196	2	22310722
Pubmed	A novel mitochondrial MAVS/Caspase-8 platform links RNA virus-induced innate antiviral signaling to Bax/Bak-independent apoptosis.	MAVS CASP8	3.16e-05	2	196	2	24391214
Pubmed	Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders.	CACNA1C SYNE1	3.16e-05	2	196	2	27620326
Pubmed	USP10-mediated deubiquitination of NR3C1 regulates bone homeostasis by controlling CST3 expression.	NR3C1 USP10	3.16e-05	2	196	2	39236936
Pubmed	Increased pachyonychia congenita severity in patients with concurrent keratin and filaggrin mutations.	FLG KRT16	3.16e-05	2	196	2	19785597
Pubmed	Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines.	VCAN CSPG4	3.16e-05	2	196	2	16625365
Pubmed	Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma.	NOTCH1 CDH1	3.16e-05	2	196	2	27167202
Pubmed	Lysine-specific Demethylase 6A Upregulates Cadherin-1 and Accelerates Gastric Cancer Growth.	KDM6A CDH1	3.16e-05	2	196	2	36941815
Pubmed	Polycystin-1L2 is a novel G-protein-binding protein.	PKD1L1 PKD1L2	3.16e-05	2	196	2	15203210
Pubmed	Temporal expression of calcium channel subunits in satellite cells and bone marrow mesenchymal cells.	CACNA1C CACNA1S	3.16e-05	2	196	2	25277766
Pubmed	Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A.	PPP2CA PPP2CB	3.16e-05	2	196	2	2555176
Pubmed	Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.	VCAN CSPG4	3.16e-05	2	196	2	15609081
Pubmed	The m6A methyltransferase METTL3 promotes trophoblast cell invasion by regulating MYLK expression.	METTL3 MYLK	3.16e-05	2	196	2	36170767
Pubmed	Rethinking isolated cleft lip and palate as a syndrome.	IGSF9 HMCN1	3.16e-05	2	196	2	29500156
Pubmed	Hypermethylated FAM5C and MYLK in serum as diagnosis and pre-warning markers for gastric cancer.	BRINP3 MYLK	3.16e-05	2	196	2	22377736
Pubmed	Effects of histamine H1 receptor signaling on glucocorticoid receptor activity. Role of canonical and non-canonical pathways.	HRH1 NR3C1	3.16e-05	2	196	2	26635083
Pubmed	A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice.	CACNA1C CACNA1S	3.16e-05	2	196	2	1281468
Pubmed	Clinicopathological Impact of Gene Polymorphism of Nephrin and Glucocorticoid Receptor Genes in Egyptian Children with Nonfamilial Nephrotic Syndrome.	NPHS1 NR3C1	3.16e-05	2	196	2	35946274
Pubmed	[Association of single nucleotide polymorphisms of CSPG2 and HSPG2 genes with intracranial aneurysm in ethnic Han Chinese population].	HSPG2 VCAN	3.16e-05	2	196	2	23568740
Pubmed	Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart.	PPP2CA PPP2CB	3.16e-05	2	196	2	11113010
Pubmed	Barrier proteins and eosinophilic esophagitis in children: the role of E-cadherin and filaggrin.	FLG CDH1	3.16e-05	2	196	2	35789411
Pubmed	Kidins220/ARMS interacts with Pdzrn3, a protein containing multiple binding domains.	KIDINS220 PDZRN3	3.16e-05	2	196	2	22609016
Pubmed	Suppression of antigen-specific CD4+ T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell.	MSR1 CD4	3.16e-05	2	196	2	22083206
Pubmed	A RAS recruitment screen identifies ZKSCAN4 as a glucocorticoid receptor-interacting protein.	NR3C1 ZKSCAN4	3.16e-05	2	196	2	19008334
Pubmed	Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities.	PPP2CA PPP2CB	3.16e-05	2	196	2	34902541
Pubmed	Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes.	PPP2CA PPP2CB	3.16e-05	2	196	2	2837763
Pubmed	TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway.	NOTCH1 TCF12	3.16e-05	2	196	2	39113057
Interaction	NDC80 interactions	CEP85L KIZ BIRC6 PLEKHG1 NUFIP2 HERC1 CAMSAP2 DYNC1I2 RPGRIP1L PPIL4 HIP1R CEP192 C2CD3 AKAP9 CEP250 CEP295 PCNT	1.15e-08	312	196	17	int:NDC80
Interaction	KRT8 interactions	WBP2 TTC3 BIRC6 PLEKHG1 CAMSAP2 HECTD1 SEL1L RPGRIP1L KRT16 KRT28 ELP1 CEP192 CD4 AKAP9 CDH1 PDZRN3 PCNT	1.58e-06	441	196	17	int:KRT8
Interaction	NIN interactions	CEP85L KIZ PLEKHG1 BRCA2 CAMSAP2 HECTD1 DYNC1I2 RPGRIP1L CEP192 C2CD3 ARSL CEP250 CEP295 PDZRN3 PCNT	2.50e-06	359	196	15	int:NIN
Interaction	PCM1 interactions	TRAF3IP1 CEP85L KIZ TTC3 PLEKHG1 CAMSAP2 RPGRIP1L KRT16 CEP192 PPP2CA C2CD3 AKAP9 CEP250 CEP295 PDZRN3 PCNT	5.70e-06	434	196	16	int:PCM1
Interaction	TOP3B interactions	UBAP2 TTC3 BIRC6 C2CD2L PLEKHG1 XPO6 NUFIP2 LRRC56 HERC1 HECTD1 PLXNA1 NOTCH1 VDAC2 HSPG2 KALRN HIP1R ARFGEF2 LMTK2 LAMA5 APOB FRYL CEP192 IDUA PIKFYVE PPP2CB USP10 C2CD3 CSPG4 HELZ2 ZNF839 HCFC1 PCNT	1.41e-05	1470	196	32	int:TOP3B
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MYLK ALPK3 IGSF9 HSPG2 KALRN HMCN1 SIGLEC11 MDGA1 ALPK2	6.07e-06	161	145	9	593
GeneFamily	Immunoglobulin like domain containing	FCER1A ALPK3 IGSF9 NPHS1 HSPG2 MDGA1 PDCD1LG2	9.47e-04	193	145	7	594
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 CSPG4	1.31e-03	7	145	2	570
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP5 ARFGEF2 AKAP9	1.58e-03	29	145	3	396
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	SP3 ZNF845 HIVEP1 ZNF767P ZNF600 ZNF320 ZNF620 ZNF407 ZXDB ZBTB34 ZNF17 ZNF611 ZNF525 ZKSCAN4	1.92e-03	718	145	14	28
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	SPAG1 TTC3 KDM6A RANBP2 SGTA	2.34e-03	115	145	5	769
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SP3 HIVEP1 GPATCH8 KIDINS220 BRCA2 XPO6 ARHGAP29 CAMSAP2 NPAT RANBP2 TCF12 PPFIA1 CASP8 FRYL NR3C1 PIKFYVE PPP2CA C2CD3 SLC25A12 AKAP9 MAP4K5 PCNT	4.69e-07	856	195	22	M4500
Coexpression	GSE3982_EOSINOPHIL_VS_MAC_UP	METTL3 ISG20 KDM6A NOTCH1 RANBP2 WIPI1 SYNE1 APOB NXN PKNOX2	2.38e-06	197	195	10	M5401
Coexpression	NABA_MATRISOME	BRINP3 COL6A5 COL24A1 FCN2 C1QTNF2 SERPINF2 PLXNA1 FLG HSPG2 COL15A1 TSPEAR LAMA5 FREM3 EGF HMCN1 VWA5A VCAN CSPG4 SLIT1 TGM7 HCFC1 SERPINA5	8.81e-06	1026	195	22	M5889
Coexpression	NABA_BASEMENT_MEMBRANES	COL6A5 HSPG2 COL15A1 LAMA5 HMCN1	1.15e-05	40	195	5	M5887
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	SP3 CEP85L USP25 GPATCH8 BIRC6 KIDINS220 PTPRJ XPO6 NUFIP2 TRPV2 BOD1L1 HERC1 NOTCH1 NPAT RANBP2 SYNE1 ELP1 CASP8 FRYL SH2D2A NR3C1 CDC42EP3 PIKFYVE CD4 AKAP9 VWA5A TRAM1	1.75e-05	1492	195	27	M40023
Coexpression	NABA_MATRISOME	BRINP3 COL6A5 COL24A1 FCN2 C1QTNF2 SERPINF2 PLXNA1 HSPG2 COL15A1 TSPEAR LAMA5 FREM3 EGF HMCN1 VWA5A VCAN CSPG4 SLIT1 TGM7 HCFC1 SERPINA5	2.19e-05	1008	195	21	MM17056
Coexpression	GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_UP	KIZ TRPV2 NPAT ATL3 CCNT1 TRAM1 TLE6 PDCD1LG2	3.16e-05	163	195	8	M6915
Coexpression	NABA_CORE_MATRISOME	COL6A5 COL24A1 HSPG2 COL15A1 TSPEAR LAMA5 HMCN1 VWA5A VCAN SLIT1	3.72e-05	270	195	10	MM17057
Coexpression	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	BRINP3 PROM1 FCN2 STOML2 KRT16 CDC42EP3 SLC22A18 EGF AKAP9 VWA5A CDH1	3.87e-05	329	195	11	M2631
Coexpression	NABA_CORE_MATRISOME	COL6A5 COL24A1 HSPG2 COL15A1 TSPEAR LAMA5 HMCN1 VWA5A VCAN SLIT1	4.34e-05	275	195	10	M5884
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	HIVEP1 ARHGAP29 CAMSAP2 TCF12 PPFIA1 CASP8 FRYL NR3C1 PIKFYVE PPP2CA C2CD3 AKAP9 MAP4K5	5.04e-05	466	195	13	M13522
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	UBAP2 BIRC6 HERC1 RPGRIP1L FRYL ATAD2 BAZ2A HCFC1	6.38e-05	180	195	8	M8239
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	MYLK PLEKHG1 BNIP3L KIDINS220 CAMSAP2 KDM6A NOTCH1 SEC16B WIPI1 TCF12 KALRN SYNE1 HIP1R BTBD17 CEP192 CDC42EP3 PPP2CA VWA5A MAP4K5 FOXP1 CEP295	7.87e-05	1102	195	21	M2369
Coexpression	HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED	HMCN1 CSPG4 HCFC1	8.49e-05	12	195	3	M47998
Coexpression	KIM_MYC_AMPLIFICATION_TARGETS_DN	SPAG1 PLEKHG1 PRUNE2 TCF19 ATL3 CDH1	9.36e-05	98	195	6	M6319
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	MYLK PLEKHG1 BNIP3L KIDINS220 CAMSAP2 KDM6A NOTCH1 SEC16B WIPI1 TCF12 KALRN SYNE1 HIP1R BTBD17 CEP192 CDC42EP3 PPP2CA VWA5A MAP4K5 FOXP1 CEP295	1.04e-04	1124	195	21	MM1070
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	MYLK PROM1 RBMS3 ARHGAP29 HRH1 PRUNE2 SYNE1 PKNOX2 VCAN ALPK2	4.83e-09	172	195	10	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRINP3 MYLK COL24A1 PRUNE2 COL15A1 PCDHA10 APOB ZNF385D HMCN1 MDGA1	7.89e-09	181	195	10	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK COL6A5 PLEKHG1 RBMS3 CACNA1C COL15A1 SYNE1 HMCN1 VCAN PDZRN3	2.04e-08	200	195	10	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	COL24A1 FCER1A PTPRJ SERPINF2 LMTK2 NR3C1 EDEM3 CD4 PDZRN3	9.16e-08	177	195	9	43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DCHS2 MYLK RBMS3 ARHGAP29 HRH1 SYNE1 PKNOX2 VCAN ALPK2	1.01e-07	179	195	9	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	SP3 MYLK TRAF3IP1 BIRC6 BOD1L1 NPAT VPS13D HMCN1 CEP295	1.40e-07	186	195	9	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PROM1 ARHGAP29 HRH1 NPHS1 SYNE1 NXN PKNOX2 CDH1 ALPK2	1.53e-07	188	195	9	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PROM1 ARHGAP29 HRH1 NPHS1 SYNE1 NXN PKNOX2 CDH1 ALPK2	1.53e-07	188	195	9	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	EPB41L4A PLEKHG1 RBMS3 ARHGAP29 HSPG2 HMCN1 VCAN FOXP1 RAI14	1.60e-07	189	195	9	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DCHS2 MYLK COL6A5 COL24A1 CACNA1C COL15A1 HMCN1 VCAN PDZRN3	2.28e-07	197	195	9	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	MYLK RBMS3 CACNA1C COL15A1 KALRN PKNOX2 HMCN1 VCAN PDZRN3	2.28e-07	197	195	9	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRINP3 MYLK ALPK3 PRUNE2 CACNA1C SYNE1 ZNF385D FAM153B PDZRN3	2.28e-07	197	195	9	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYLK RBMS3 CACNA1C KALRN PKNOX2 ZNF385D HMCN1 VCAN PDZRN3	2.38e-07	198	195	9	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRINP3 MYLK ALPK3 PRUNE2 CACNA1C KALRN SYNE1 ZNF385D PDZRN3	2.38e-07	198	195	9	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRINP3 MYLK ALPK3 PRUNE2 CACNA1C SYNE1 ZNF385D FAM153B PDZRN3	2.38e-07	198	195	9	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC168 HRH1 NPHS1 PRUNE2 SYNE1 LAMA5 SLIT1 ALPK2	4.98e-07	158	195	8	e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC168 HRH1 NPHS1 PRUNE2 SYNE1 LAMA5 SLIT1 ALPK2	4.98e-07	158	195	8	d39e020c3e77eb9d3de600a171d22f94357061d4
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DCHS2 MYLK KCND2 ARHGAP29 NPHS1 CACNA1C SYNE1 PDCD1LG2	8.67e-07	170	195	8	f0b0d2d0402de3ed7322284a599646db43475761
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DCHS2 MYLK KCND2 ARHGAP29 NPHS1 CACNA1C SYNE1 PDCD1LG2	8.67e-07	170	195	8	054360a3b05f5e41221c98b122d241b1affad26a
ToppCell	Control-Endothelial_cells-Systemic_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	PKD1L1 EPB41L4A PLEKHG1 ARHGAP29 HSPG2 COL15A1 KALRN ZNF385D	9.47e-07	172	195	8	c55dce1ed3ed7312394b4e050e1de852a994e130
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BRINP3 MYLK PRUNE2 CACNA1C COL15A1 KALRN ZNF385D PDZRN3	9.89e-07	173	195	8	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	AT1_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	RBMS3 PLXNA1 HSPG2 LAMA5 FREM3 NXN MDGA1 GPRIN2	1.13e-06	176	195	8	458720776b0151cd55acc352d509599cb62f0ca8
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DCHS2 MYLK PROM1 ARHGAP29 HRH1 PRUNE2 PKNOX2 ALPK2	1.23e-06	178	195	8	544379f5a6145429762258d426b876bb36c112f5
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	MYLK PRUNE2 CACNA1C COL15A1 KALRN ZNF385D VCAN PDZRN3	1.33e-06	180	195	8	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL24A1 HRH1 CACNA1C KALRN NXN ZNF385D VCAN PDZRN3	1.45e-06	182	195	8	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RBMS3 CACNA1C NR3C1 MSR1 PKNOX2 ZNF385D VCAN RAI14	1.64e-06	185	195	8	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	EPB41L4A PLEKHG1 ARHGAP29 HSPG2 KALRN NXN ZNF385D RAI14	1.64e-06	185	195	8	f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BRINP3 RBMS3 TCF12 NR3C1 MSR1 PKNOX2 ZNF385D VCAN	1.70e-06	186	195	8	7def03dd856b765bd3f493288641981c4f7fd26e
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	BRINP3 MYLK COL24A1 RBMS3 CACNA1C COL15A1 HMCN1 PDZRN3	1.77e-06	187	195	8	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK PROM1 COL24A1 C1QTNF2 PRUNE2 SYNE1 ZNF385D PDZRN3	1.84e-06	188	195	8	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EPB41L4A PLEKHG1 ARHGAP29 HSPG2 KALRN NXN ZNF385D RAI14	2.00e-06	190	195	8	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPAG1 HERC1 KDM6A RANBP2 PPIL4 HIP1R ARFGEF2 BAZ2A	2.08e-06	191	195	8	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYLK CACNA1C KALRN PKNOX2 ZNF385D HMCN1 VCAN PDZRN3	2.33e-06	194	195	8	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	MYLK COL24A1 KCND2 RBMS3 CACNA1C HMCN1 VCAN PDZRN3	2.33e-06	194	195	8	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)\|356C / Donor, Lineage, Cell class and subclass (all cells)	RBMS3 PLXNA1 HSPG2 LAMA5 FREM3 NXN MDGA1 GPRIN2	2.42e-06	195	195	8	07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	RBMS3 PLXNA1 HSPG2 LAMA5 FREM3 NXN MDGA1 GPRIN2	2.42e-06	195	195	8	b65511770ed67f7447847e2187555b362988af45
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	EPB41L4A PLEKHG1 ARHGAP29 HSPG2 KALRN SYNE1 FRYL HMCN1	2.61e-06	197	195	8	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK PRUNE2 CACNA1C COL15A1 KALRN ZNF385D CSPG4 PDZRN3	2.71e-06	198	195	8	bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	USP25 BIRC6 PTPRJ ZCCHC7 HERC1 KDM6A TCF12 ZNF407	2.82e-06	199	195	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK PRUNE2 CACNA1C COL15A1 KALRN ZNF385D CSPG4 PDZRN3	2.82e-06	199	195	8	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLEKHG1 ARHGAP29 HSPG2 COL15A1 LAMA5 CDC42EP3 ZNF385D RAI14	2.82e-06	199	195	8	258d59cf811bf1668ffbb5f18f961021f660de62
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	MYLK PROM1 C1QTNF2 PRUNE2 SYNE1 ZNF385D MAP4K5 PDZRN3	2.92e-06	200	195	8	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK KCND2 RBMS3 CACNA1C PKNOX2 HMCN1 VCAN PDZRN3	2.92e-06	200	195	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK RBMS3 CACNA1C COL15A1 SYNE1 HMCN1 VCAN PDZRN3	2.92e-06	200	195	8	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	MYLK PROM1 C1QTNF2 PRUNE2 SYNE1 ZNF385D MAP4K5 PDZRN3	2.92e-06	200	195	8	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYLK PROM1 C1QTNF2 PRUNE2 SYNE1 ZNF385D MAP4K5 PDZRN3	2.92e-06	200	195	8	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Sigmoid-T_cell-Tfh\|T_cell / Region, Cell class and subclass	HRH1 NOTCH1 FDXACB1 FREM3 SLC25A12 HELZ2 ZNF525 ZKSCAN4	2.92e-06	200	195	8	dd7dcf25520f065bf0d33d589f3c176f63875dc9
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK PRUNE2 CACNA1C ZNF385D HMCN1 CSPG4 PDZRN3	6.60e-06	159	195	7	7cda111bb98f1241989e49d490bdf51a712ea589
ToppCell	RV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	MYLK TRPV2 PRUNE2 CACNA1C KALRN NXN ZNF385D	6.87e-06	160	195	7	29c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCNH7 CA10 RXFP2 FRMPD1 ZNF385D EGF SERPINA5	6.87e-06	160	195	7	8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCNH7 CA10 RXFP2 FRMPD1 ZNF385D EGF SERPINA5	6.87e-06	160	195	7	2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	ALPK3 PRUNE2 CACNA1C KALRN ZNF385D HCFC1 PDZRN3	7.16e-06	161	195	7	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	facs-Marrow-KLS-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPAG1 FCER1A CACNA1C CSRP3 ZKSCAN4 MDGA1 CDH1	9.09e-06	167	195	7	2812353ff66e76f10bd327ceb0e6b009502a5258
ToppCell	facs-Marrow-KLS-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPAG1 FCER1A CACNA1C CSRP3 ZKSCAN4 MDGA1 CDH1	9.09e-06	167	195	7	d15168f46c1599d9fc68a05a7b822c4b439f2987
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	MYLK PRUNE2 CACNA1C COL15A1 KALRN ZNF385D PDZRN3	1.14e-05	173	195	7	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KCNH7 CA10 ALPK3 FRMPD1 ZNF385D EGF HMCN1	1.14e-05	173	195	7	4bc6d93716f093b460c8b047199db8cab5fea720
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AKAP5 TCF12 TCF19 SYNE1 SH2D2A ZNF17 ZNF839	1.23e-05	175	195	7	26bd957498e41a3f1ffa60d3effa27ca8c4ba631
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEP85L ARHGAP29 RANBP2 SYNE1 NR3C1 CDC42EP3 AKAP9	1.38e-05	178	195	7	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	AT1_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	RBMS3 PLXNA1 HSPG2 LAMA5 FREM3 MDGA1 GPRIN2	1.43e-05	179	195	7	1603117b52623663458a977c94bf7f9f6c1114b8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KCNH7 CA10 ALPK3 FRMPD1 ZNF385D EGF HMCN1	1.53e-05	181	195	7	e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 PROM1 ARHGAP29 HRH1 SYNE1 PKNOX2 VCAN	1.53e-05	181	195	7	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	facs-Marrow-T-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP25 FCER1A LAMA5 CSRP3 MSR1 CD4 CDH1	1.53e-05	181	195	7	7286700396676fdc41d9723979b8b408177aceb9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 PROM1 ARHGAP29 HRH1 SYNE1 PKNOX2 VCAN	1.53e-05	181	195	7	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLEKHG1 GP1BA TSPEAR HMCN1 RAI14 SERPINA5 PDCD1LG2	1.59e-05	182	195	7	f231e86524b628e6e11ac33d5c34be99d454a92a
ToppCell	COVID-19-Neuronal_cells-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	PLEKHG1 ARHGAP29 KALRN TSPEAR NXN ZNF385D RAI14	1.77e-05	185	195	7	4a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCell	COVID-19-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	PLEKHG1 ARHGAP29 KALRN TSPEAR NXN ZNF385D RAI14	1.77e-05	185	195	7	36ce23893915f5c380cca39b2c33a516edf31c3a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK PROM1 COL24A1 PRUNE2 CACNA1C ZNF385D PDZRN3	1.83e-05	186	195	7	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	COPD-Endothelial-VE_Peribronchial\|COPD / Disease state, Lineage and Cell class	PLEKHG1 ARHGAP29 HSPG2 COL15A1 KALRN ZNF385D RAI14	1.83e-05	186	195	7	23c7d0e8372a71546d687278b985f761d282f92f
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	EPB41L4A PLEKHG1 RBMS3 ARHGAP29 HSPG2 KALRN ZNF385D	1.89e-05	187	195	7	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	MYLK RBMS3 PRUNE2 CACNA1C KALRN VCAN PDZRN3	1.89e-05	187	195	7	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	EPB41L4A PLEKHG1 ARHGAP29 HSPG2 KALRN NXN ZNF385D	1.96e-05	188	195	7	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	CEP85L BIRC6 NUFIP2 HERC1 KDM6A RANBP2 ZNF407	1.96e-05	188	195	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	BRINP3 KCND2 RBMS3 CACNA1C ZNF385D VCAN PDZRN3	1.96e-05	188	195	7	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BRINP3 MYLK HRH1 PRUNE2 CACNA1C COL15A1 ZNF385D	1.96e-05	188	195	7	4d1e5f85342ae550086609d7680e32730b78b5d2
ToppCell	cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HIVEP1 PLEKHG1 CEP68 BRCA2 KALRN CEP250 ZNF839	2.03e-05	189	195	7	bccb3481ffed597c845fe860da658505316105b5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK PROM1 COL24A1 PRUNE2 CACNA1C SYNE1 PDZRN3	2.03e-05	189	195	7	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KCNH7 CA10 ARHGAP29 HECTD1 EGF HMCN1 CDH1	2.03e-05	189	195	7	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	MYLK RBMS3 CACNA1C PKNOX2 HMCN1 VCAN PDZRN3	2.10e-05	190	195	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK PROM1 C1QTNF2 PRUNE2 CACNA1C SYNE1 PDZRN3	2.17e-05	191	195	7	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RBMS3 CACNA1C KALRN PKNOX2 ZNF385D VCAN PDZRN3	2.17e-05	191	195	7	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	IPF-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	PLEKHG1 PTPRJ RBMS3 ARHGAP29 HRH1 NXN HMCN1	2.24e-05	192	195	7	356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK COL24A1 KCND2 CACNA1C COL15A1 HMCN1 PDZRN3	2.24e-05	192	195	7	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	Pericytes\|World / lung cells shred on cell class, cell subclass, sample id	MYLK C1QTNF2 CACNA1C COL15A1 CSPG4 SLIT1 PDZRN3	2.24e-05	192	195	7	057ad22b878c0c5fb59ed1412ca13db945c57a5a
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYLK CACNA1C MSR1 ZNF385D HMCN1 SLIT1 PDZRN3	2.32e-05	193	195	7	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	BRINP3 MYLK COL24A1 RBMS3 CACNA1C HMCN1 PDZRN3	2.32e-05	193	195	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ZNF845 BIRC6 HECTD1 RANBP2 FRYL AKAP9 BAZ2A	2.32e-05	193	195	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	COVID-19-Endothelial_cells-Inflamed_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	EPB41L4A PLEKHG1 ARHGAP29 KALRN SYNE1 LAMA5 RAI14	2.32e-05	193	195	7	979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	MYLK COL6A5 CACNA1C COL15A1 PKNOX2 HMCN1 PDZRN3	2.32e-05	193	195	7	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK COL24A1 KCND2 CACNA1C COL15A1 HMCN1 PDZRN3	2.32e-05	193	195	7	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RBMS3 GP1BA NPHS1 PRUNE2 HMCN1 SERPINA5 ALPK2	2.40e-05	194	195	7	f9fbb043411546d8c9e0321a64165d411f44aeb7
ToppCell	facs-Skin-Anagen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF12 LMTK2 NXN HMCN1 TRAM1 FOXP1 PDZRN3	2.40e-05	194	195	7	5d30d3d41d5f19cdf3077cc609aa2738762cb8c5
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	EPB41L4A PLEKHG1 RBMS3 ARHGAP29 HSPG2 HMCN1 FOXP1	2.40e-05	194	195	7	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BRINP3 MYLK MSR1 ZNF385D HMCN1 SLIT1 PDZRN3	2.40e-05	194	195	7	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	IPF-Endothelial\|IPF / Disease state, Lineage and Cell class	PLEKHG1 ARHGAP29 HSPG2 COL15A1 KALRN ZNF385D RAI14	2.40e-05	194	195	7	9591993aa2dcba3d09a0f1ea8b8f2439c26482d6
ToppCell	IPF-Endothelial-VE_Peribronchial\|World / Disease state, Lineage and Cell class	PLEKHG1 ARHGAP29 HSPG2 COL15A1 KALRN ZNF385D RAI14	2.48e-05	195	195	7	120296531bbc8080dcabacbd64733cc1dc34603a
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	EPB41L4A PLEKHG1 ARHGAP29 KALRN SYNE1 ZNF385D HMCN1	2.48e-05	195	195	7	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RBMS3 GP1BA NPHS1 PRUNE2 HMCN1 SERPINA5 ALPK2	2.48e-05	195	195	7	1be9502577267ca2a04656a99d57e3e2f124d92e
ToppCell	IPF-Endothelial-VE_Peribronchial\|IPF / Disease state, Lineage and Cell class	PLEKHG1 ARHGAP29 HSPG2 COL15A1 KALRN ZNF385D RAI14	2.48e-05	195	195	7	2c3ad3cb79f11119ac69c413a938d21199145040
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PLEKHG1 RBMS3 FCN2 CACNA1C HSPG2 KALRN NXN	2.48e-05	195	195	7	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KCNH7 ZNF385D SPPL2A EGF HMCN1 SLC2A12 SERPINA5	2.48e-05	195	195	7	a38d9dc6192aea673d96fda6b25e81223fda3abf
Disease	alcohol and nicotine codependence	HIVEP1 PLEKHG1 KCND2 PKNOX2	1.16e-06	13	191	4	EFO_0004776
Disease	BREAST CANCER	BRCA2 CASP8 SLC22A18 CDH1	9.34e-06	21	191	4	114480
Disease	Malignant tumor of breast	BRCA2 CASP8 SLC22A18 CDH1	2.66e-05	27	191	4	cv:C0006142
Disease	Breast neoplasm	BRCA2 CASP8 SLC22A18 CDH1	2.66e-05	27	191	4	cv:C1458155
Disease	Familial cancer of breast	BRCA2 CASP8 SLC22A18 CDH1	2.66e-05	27	191	4	cv:C0346153
Disease	Congenital aneurysm of ascending aorta	MYLK NOTCH1	4.17e-05	2	191	2	C0345050
Disease	immunoglobulin E measurement	STAT6 FCER1A	4.17e-05	2	191	2	EFO_0020464
Disease	emphysema imaging measurement	ZNF600 RBMS3 SEC16B NXN FAM135B RIMBP2 ZNF839	4.85e-05	146	191	7	EFO_0007626
Disease	Malignant neoplasm of breast	CEP85L SIX4 TTC3 BRCA2 ARHGAP29 BOD1L1 NOTCH1 KALRN SYNE1 FRMPD1 ARFGEF2 ELP1 CASP8 SLC22A18 EGF AKAP9 CLSPN CDH1 HSPA14	7.58e-05	1074	191	19	C0006142
Disease	Prostate cancer, familial	BRCA2 CASP8 MSR1 PKNOX2 CDH1	8.66e-05	69	191	5	C2931456
Disease	tubulointerstitial nephritis antigen-like measurement	HSPG2 MAP4K5	1.25e-04	3	191	2	EFO_0803197
Disease	bilirubin measurement	DCHS2 PKD1L2 BIRC6 WIPI1 ZNF407 APOB SH2D2A SLC22A18 EGF MAP4K5 ISG20L2	1.56e-04	442	191	11	EFO_0004570
Disease	bitter beverage consumption measurement	ZCCHC7 VDAC2 EDEM3 MAP4K5	1.57e-04	42	191	4	EFO_0010089
Disease	Colorectal Carcinoma	PROM1 FCN2 HRH1 CAMSAP2 KDM6A KALRN SYNE1 TSPEAR CASP8 APOB NXN ZNF385D AKAP9 CDH1	2.08e-04	702	191	14	C0009402
Disease	lung adenocarcinoma (biomarker_via_orthology)	NOTCH1 FOXP1	2.48e-04	4	191	2	DOID:3910 (biomarker_via_orthology)
Disease	Timothy syndrome (implicated_via_orthology)	CACNA1C CACNA1S	2.48e-04	4	191	2	DOID:0060173 (implicated_via_orthology)
Disease	esophagus adenocarcinoma (is_implicated_in)	CASP8 SLC22A18 FOXP1	3.26e-04	21	191	3	DOID:4914 (is_implicated_in)
Disease	suicide ideation measurement	BRINP3 EPB41L4A	4.12e-04	5	191	2	EFO_0007619
Disease	ficolin-2 measurement	NXPE4 FCN2	4.12e-04	5	191	2	EFO_0008135
Disease	SUN domain-containing protein 3 measurement	NXPE4 FCN2	4.12e-04	5	191	2	EFO_0802102
Disease	cerebellar ataxia (is_implicated_in)	RPGRIP1L SYNE1	4.12e-04	5	191	2	DOID:0050753 (is_implicated_in)
Disease	platelet component distribution width	CEP68 MAVS CAMTA1 HERC1 GP1BA PRUNE2 CACNA1C KALRN SYNE1 LAMA5 NXN C4orf54 EGF BAZ2A	4.31e-04	755	191	14	EFO_0007984
Disease	obsolete_red blood cell distribution width	SP3 ARFIP1 BIRC6 PLEKHG1 BNIP3L NUFIP2 HERC1 NOTCH1 FDXACB1 WIPI1 KALRN HIP1R ZNF407 APOB FREM3 APLF MAP4K5 HELZ2 ZNF611 CDH1	4.91e-04	1347	191	20	EFO_0005192
Disease	coronary artery disease (is_implicated_in)	BRINP3 MYLK KALRN APOB NR3C1	4.94e-04	100	191	5	DOID:3393 (is_implicated_in)
Disease	platelet crit	GPATCH8 ZNF320 ARHGAP29 GP1BA NPAT CACNA1C KALRN LAMA5 CASP8 ZNF407 APOB SH2D2A NXN EGF MAP4K5 ISG20L2	4.97e-04	952	191	16	EFO_0007985
Disease	MEDULLOBLASTOMA	BRCA2 ELP1	6.15e-04	6	191	2	155255
Disease	Medulloblastoma	BRCA2 ELP1	6.15e-04	6	191	2	cv:C0025149
Disease	testosterone measurement	DCHS2 BIRC6 CEP68 PTPRJ RBMS3 RXFP2 NUFIP2 SERPINF2 VDAC2 TCF12 DNAH2 NR3C1 MSR1 PKNOX2 SLC22A18 HMCN1 MAP4K5 FOXP1 RIMBP2	6.53e-04	1275	191	19	EFO_0004908
Disease	QT interval	SP3 CEP85L PROM1 PTPRJ NUFIP2 ALPK3 SH2D2A ZNF385D FOXP1 SLC2A12 PDZRN3	7.64e-04	534	191	11	EFO_0004682
Disease	creatinine measurement	BIRC6 C2CD2L PTPRJ VDAC2 NPHS1 CACNA1S WIPI1 TCF12 LAMA5 SCLY FAM135B EDEM3 USP10 SPPL2A MAP4K5 CSPG4	7.96e-04	995	191	16	EFO_0004518
Disease	alpha-1-antichymotrypsin complex measurement	PIKFYVE SERPINA5	8.57e-04	7	191	2	EFO_0008018
Disease	infertility (implicated_via_orthology)	METTL3 BRCA2	8.57e-04	7	191	2	DOID:5223 (implicated_via_orthology)
Disease	glucose measurement	EPB41L4A PTPRJ NUFIP2 HERC1 WIPI1 ELP1 EDEM3 MAP4K5 ISG20L2	8.76e-04	380	191	9	EFO_0004468
Disease	Breast Cancer, Familial	BRCA2 SLC22A18 CDH1	9.53e-04	30	191	3	C0346153
Disease	Major Depressive Disorder	PROM1 CACNA1C KALRN NR3C1 FREM3 EGF PCNT	1.08e-03	243	191	7	C1269683
Disease	sialic acid-binding Ig-like lectin 12 measurement	KALRN MAP4K5	1.14e-03	8	191	2	EFO_0802066
Disease	cutaneous squamous cell carcinoma	BRCA2 CASP8 FOXP1	1.26e-03	33	191	3	EFO_1001927
Disease	Adult Hepatocellular Carcinoma	CASP8 EGF	1.46e-03	9	191	2	C0279607
Disease	Glioma	BRCA2 ELP1	1.46e-03	9	191	2	cv:C0017638
Disease	Malignant tumor of prostate	BRCA2 CDH1	1.46e-03	9	191	2	cv:C0376358
Disease	Cleft palate with cleft lip	ARHGAP29 CDH1	1.46e-03	9	191	2	C0158646
Disease	Unipolar Depression	PROM1 CACNA1C KALRN NR3C1 FREM3 EGF PCNT	1.55e-03	259	191	7	C0041696
Disease	endometrial cancer (is_implicated_in)	BRCA2 EGF CDH1	1.63e-03	36	191	3	DOID:1380 (is_implicated_in)
Disease	amino acid measurement	CA10 COL24A1 PTPRJ RXFP2 CAMTA1 NOTCH1 TCF12 SYNE1 CD4 MAP4K5 VCAN SLIT1	1.63e-03	678	191	12	EFO_0005134
Disease	bitter alcoholic beverage consumption measurement	STAT6 KCND2 DNAH2 ZNF385D MAP4K5	1.78e-03	133	191	5	EFO_0010092
Disease	medulloblastoma (is_implicated_in)	BRCA2 ELP1	1.81e-03	10	191	2	DOID:0050902 (is_implicated_in)
Disease	Abnormality of nervous system morphology	DYNC1I2 PPP2CA	1.81e-03	10	191	2	C4022810
Disease	level of Triacylglycerol (51:3) in blood serum	APOB MAP4K5	1.81e-03	10	191	2	OBA_2045163
Disease	red blood cell density measurement	SP3 HIVEP1 BNIP3L RBMS3 CAMTA1 CACNA1C KALRN DNAH2 ARFGEF2 CSRP3 SPPL2A MAP4K5 FOXP1 RAI14	1.86e-03	880	191	14	EFO_0007978
Disease	cytochrome p450 3a4 measurement	APOB PIKFYVE	2.21e-03	11	191	2	EFO_0020303
Disease	Barrett's esophagus (is_implicated_in)	MSR1 FOXP1	2.21e-03	11	191	2	DOID:9206 (is_implicated_in)
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	APOB MAP4K5	2.21e-03	11	191	2	OBA_2045170
Disease	Malignant neoplasm of urinary bladder	BRCA2 KDM6A NOTCH1 KRT16 CDH1	2.29e-03	141	191	5	C0005684
Disease	Neoplasm of uncertain or unknown behavior of breast	BRCA2 NOTCH1 CASP8	2.37e-03	41	191	3	C0496956
Disease	Breast adenocarcinoma	BRCA2 NOTCH1 CASP8	2.37e-03	41	191	3	C0858252
Disease	hematocrit	HIVEP1 UBAP2 EPB41L4A PLEKHG1 PTPRJ RBMS3 CACNA1C KALRN DNAH2 APOB NR3C1 SPPL2A MAP4K5 FOXP1 RAI14	2.52e-03	1011	191	15	EFO_0004348
Disease	alkaline phosphatase measurement	PTPRJ XPO6 NUFIP2 SERPINF2 NOTCH1 HSPG2 SEC16B WIPI1 APOB EDEM3 MAP4K5 SS18L1 RAI14 ALPK2 PDCD1LG2	2.62e-03	1015	191	15	EFO_0004533
Disease	coffee consumption measurement, tea consumption measurement	PTPRJ VDAC2 MAP4K5	2.91e-03	44	191	3	EFO_0006781, EFO_0010091
Disease	alcohol consumption measurement	KCNH7 BIRC6 STAT6 SPTBN5 BNIP3L PTPRJ KCND2 RBMS3 NUFIP2 CAMTA1 CACNA1C DNAH2 FAM135B CRB1 AKAP9 MAP4K5 FOXP1	3.05e-03	1242	191	17	EFO_0007878
Disease	gallbladder cancer (is_implicated_in)	APOB EGF	3.10e-03	13	191	2	DOID:3121 (is_implicated_in)
Disease	Primary Ciliary Dyskinesia	SPAG1 LRRC56 RPGRIP1L	3.51e-03	47	191	3	C4551720
Disease	Paroxysmal atrial fibrillation	CEP68 HERC1 HSPG2 HIP1R NR3C1	3.54e-03	156	191	5	C0235480
Disease	familial atrial fibrillation	CEP68 HERC1 HSPG2 HIP1R NR3C1	3.54e-03	156	191	5	C3468561
Disease	Persistent atrial fibrillation	CEP68 HERC1 HSPG2 HIP1R NR3C1	3.54e-03	156	191	5	C2585653
Disease	Neoplasm of lung	CASP8 SLC22A18	3.60e-03	14	191	2	cv:C0024121
Disease	Lung cancer	CASP8 SLC22A18	3.60e-03	14	191	2	cv:C0242379
Disease	LUNG CANCER	CASP8 SLC22A18	3.60e-03	14	191	2	211980
Disease	reticulocyte measurement	UBAP2 ZNF767P ARFIP1 BIRC6 BNIP3L PTPRJ WIPI1 ARFGEF2 PIKFYVE USP10 EGF MAP4K5 FOXP1 RAI14 CDH1	3.68e-03	1053	191	15	EFO_0010700
Disease	reaction time measurement	KCNH7 EPB41L4A CA10 COL24A1 NUFIP2 CAMTA1 DYNC1I2 SEL1L CEP192 SLC25A12 FOXP1	3.90e-03	658	191	11	EFO_0008393
Disease	Atrial Fibrillation	CEP68 HERC1 HSPG2 HIP1R NR3C1	3.94e-03	160	191	5	C0004238
Disease	Adenoid Cystic Carcinoma	KDM6A NOTCH1 VCAN CDH1	4.11e-03	100	191	4	C0010606
Disease	Neoplasm of uncertain or unknown behavior of bladder	KDM6A NOTCH1	4.14e-03	15	191	2	C0496930
Disease	mannan-binding lectin serine protease 1 measurement	NXPE4 FCN2	4.14e-03	15	191	2	EFO_0008223
Disease	Benign neoplasm of bladder	KDM6A NOTCH1	4.14e-03	15	191	2	C0154017
Disease	triacylglycerol 52:3 measurement	APOB MAP4K5	4.14e-03	15	191	2	EFO_0010415
Disease	Carcinoma in situ of bladder	KDM6A NOTCH1	4.14e-03	15	191	2	C0154091
Disease	response to olanzapine	HIVEP1 CACNA1C	4.14e-03	15	191	2	GO_0097333
Disease	QRS amplitude, QRS complex	HIVEP1 CEP85L USP25	4.18e-03	50	191	3	EFO_0005054, EFO_0007742
Disease	gastroesophageal reflux disease	CA10 APOB VCAN FOXP1	4.26e-03	101	191	4	EFO_0003948
Disease	free cholesterol to total lipids in small HDL percentage	RNF214 WIPI1 APOB	4.43e-03	51	191	3	EFO_0022285
Disease	Abnormality of refraction	TRAF3IP1 PKD1L1 BIRC6 RBMS3 PCDHA10 SPPL2A SLC25A12 MAP4K5 TRAM1 FOXP1 RIMBP2	4.60e-03	673	191	11	HP_0000539
Disease	coffee consumption, cups of coffee per day measurement	VDAC2 MAP4K5	4.71e-03	16	191	2	EFO_0004330, EFO_0006782
Disease	Dermatitis	FLG EGF	4.71e-03	16	191	2	C0011603
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	ARHGAP29 NOTCH1	4.71e-03	16	191	2	C0334634
Disease	Familial thoracic aortic aneurysm and aortic dissection	MYLK NOTCH1 VCAN	4.93e-03	53	191	3	C4707243
Disease	response to radiation, Urinary retention	CAMTA1 ZNF385D	5.32e-03	17	191	2	GO_0009314, HP_0000016
Disease	Antihistamine use measurement	STAT6 RBMS3	5.32e-03	17	191	2	EFO_0009943
Disease	lupus nephritis (is_marker_for)	NR3C1 EGF	5.32e-03	17	191	2	DOID:0080162 (is_marker_for)
Disease	susceptibility to urinary tract infection measurement	RBMS3 SEC16B TCF12 ZKSCAN4	5.40e-03	108	191	4	EFO_0008413
Disease	upper aerodigestive tract neoplasm	BIRC6 BRCA2 RBMS3 PRUNE2 CASP8 ZKSCAN4	5.48e-03	246	191	6	EFO_0004284
Disease	polyp of colon	LAMA5 NXN CDH1	5.75e-03	56	191	3	MONDO_0021400
Disease	ovarian cancer (is_implicated_in)	BRCA2 APOB CDH1	5.75e-03	56	191	3	DOID:2394 (is_implicated_in)
Disease	nephrotic syndrome (is_marker_for)	GP1BA NR3C1	5.96e-03	18	191	2	DOID:1184 (is_marker_for)
Disease	Carcinoma of bladder	KDM6A NOTCH1	5.96e-03	18	191	2	C0699885
Disease	intraocular pressure measurement	TRAF3IP1 COL24A1 PTPRJ BOD1L1 SEL1L TCF12 KALRN CSPG4 FOXP1	6.15e-03	509	191	9	EFO_0004695
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	HIVEP1 CA10 BIRC6 KCND2 NUFIP2 CAMTA1 HERC1 ELP1 ZNF407 FAM135B FOXP1 PDZRN3	6.19e-03	801	191	12	EFO_0003888, EFO_0007052, MONDO_0002491

Protein segments in the cluster

Peptide	Gene	Start	Entry
VAVNSASQLEAHNSG	ZNF385D	211	Q9H6B1
HNGSLSEETNSSLNI	FCER1A	66	P12319
NENGLLGSFSEETHS	BRINP3	411	Q76B58
ELHAQLQSSDGTGQS	AKAP9	3321	Q99996
DASQGLVLAVSSDGH	CAMTA1	426	Q9Y6Y1
AHSEGFSVQEQLATG	COX18	196	Q8N8Q8
AQGDSLQDESQGSHS	APLF	331	Q8IW19
TSDHGGSLENQLGNT	ARSL	351	P51690
SAVNGEAQSSHETRG	BIRC6	4336	Q9NR09
TNTLENLGAQTTEHS	VCAN	1796	P13611
GQGTIDTAVLHLDTN	CSPG4	1141	Q6UVK1
SSTGSSLQGHQERAE	CEP68	201	Q76N32
SGVQHQSTLELSEVG	SERPINF2	376	P08697
LNISHTASEGATGEN	ALPK2	896	Q86TB3
GDVNVNGLSTVSHTT	BAZ2A	51	Q9UIF9
GEAAGTSINHSQAVL	BTBD17	36	A6NE02
SLSSADNLESDAQGH	ARFGEF2	346	Q9Y6D5
ETETAQHSGLGLINS	ALPK3	456	Q96L96
LGLSETQITSHGFDN	ARFIP1	41	P53367
NGDASSSQIIHISDE	ATAD2	1271	Q6PL18
TQGHRTSENLALTGV	CCNT1	346	O60563
ISRHSQAVQGQSEGS	FLG	3191	P20930
KSSLLENGTVHQGDT	CDC42EP3	156	Q9UKI2
QEHSNSVGGQDTGAT	C18orf25	271	Q96B23
HGNSGRNSESESNKV	NUP50	201	Q9UKX7
GVDVTAQDTTGHSAL	RAI14	76	Q9P0K7
TLETANKNHETDGGS	RANBP2	1146	P49792
DGGTTDTATILSNQH	PDZRN3	551	Q9UPQ7
ASSSHVTEGQTLDLN	HSPG2	2931	P98160
TGSHVNLGAITASLQ	PDCD1LG2	46	Q9BQ51
NHLSLGTTGTIQSQD	RBMS3	341	Q6XE24
SIQNSLLGHSSVEDA	ISG20	141	Q96AZ6
QSNEAASLASTGVGV	SLC2A12	311	Q8TD20
SDQHGSQFLITTGEN	PPIL4	101	Q8WUA2
NVSGQVEIHLGDSLS	NPAT	616	Q14207
RGSDTLSHSQDNGVD	MDGA1	171	Q8NFP4
TVTQAELGHLSAEGQ	HCFC1	1661	P51610
NSVSAGTQEHGITLQ	NPHS1	321	O60500
QGGVHSSLLTIANVS	NPHS1	896	O60500
IHVAGETDSSNLNVS	PTPRJ	401	Q12913
SSSGGSIHSNLEQEK	KIDINS220	1421	Q9ULH0
ASLQQQISHDSGAAT	KRT28	286	Q7Z3Y7
GSGKTVSNVITESHN	TRAF3IP1	486	Q8TDR0
HAGTTDNEKRSESQG	MYLK	1081	Q15746
QGASLHNQTDRTGET	NOTCH1	1916	P46531
QEQDTELGSTHTAGA	MAVS	196	Q7Z434
STDSTDGNLNELHIT	RPGRIP1L	781	Q68CZ1
LSSGVHLNTASEDNL	KCNH7	1126	Q9NS40
NTVLSSDQNTLDGTH	KIAA1109	2396	Q2LD37
ITNTAQSNHTGDLDT	KIAA1109	3346	Q2LD37
QSNHTGDLDTGSALV	KIAA1109	3351	Q2LD37
SSNLVGVTINIHTGD	EDEM3	266	Q9BZQ6
DGIAIQQISAGTSHS	HERC1	716	Q15751
GSTDTILIGNNHITG	KDM6A	586	O15550
GTQNAHNLISISTDG	DYNC1I2	391	Q13409
NTGNHDVASGSTILA	C1QTNF2	226	Q9BXJ5
LGGDVSDQSLESHSQ	GPATCH8	486	Q9UKJ3
IEGSHLNAGSDVAVS	PLXNA1	981	Q9UIW2
ASVDLSHDQSGDSLN	KAT14	46	Q9H8E8
SGGLDNETHFLNNTL	FRYL	1001	O94915
EDSVSLNGNHSVLSS	TCF12	471	Q99081
AEETTGNNHSSLDLT	FOXP1	241	Q9H334
DFSAGHSSELTIQVG	KALRN	1656	O60229
QVGKSGHSSVEDAQA	ISG20L2	316	Q9H9L3
LEGEDAHLSSQQASG	KRT16	421	P08779
SGSHQGSIQELSTIQ	KCND2	546	Q9NZV8
ALGQAGVSETDNSSQ	PPFIA1	826	Q13136
FSLTHLTDSDIEQGG	LMTK2	1481	Q8IWU2
GHVSNASISLGESVS	TUBGCP6	1081	Q96RT7
SDVSSEQQHLKGQTG	NR3C1	161	P04150
EHGQLNVSSSAAVDG	ELP1	541	O95163
DLGQAVLDAGHSVST	LAMA5	2671	O15230
GQDISETFNHANGLT	PPP2CB	221	P62714
GQDISETFNHANGLT	PPP2CA	221	P67775
TDASVSHLSGLNIGS	KIZ	586	Q2M2Z5
HEVSDSQAGSLQSEL	PCNT	1761	O95613
QELALTQSVGGDSSA	METTL3	351	Q86U44
LNQEHESQGSGQSLS	PKD1L2	906	Q7Z442
ANNAAGEDTHTVSLT	HMCN1	4241	Q96RW7
TLFSSVQGHGNAIDE	MSR1	161	P21757
VGELSSSQGQRGHTS	PASD1	206	Q8IV76
GSHITVVSANDRDTG	DCHS2	2681	Q6V1P9
ISVSDHDSGANGQVT	PCDHA10	371	Q9Y5I2
GVTTSLQISGDHSIN	ARHGAP29	1106	Q52LW3
AQGDATLEHSTNLDS	BOD1L1	1266	Q8NFC6
AHSTDSNSIGEDLNA	PIKFYVE	221	Q9Y2I7
SGSLNSHGLELNADI	APOB	1616	P04114
TDGGNLSSSTTLQIH	CDHR2	561	Q9BYE9
SHLAADTIINGGATS	HIP1R	696	O75146
EHGTKSGLNQGAIST	HECTD1	1956	Q9ULT8
GLQHSLNSGQSLESV	C2CD3	256	Q4AC94
LHINKAGSSQGDTES	CACNA1C	1776	Q13936
LNVEGGSSENNHSIK	BRCA2	2136	P51587
EAGLSQSHDDLSNAT	C2CD2L	656	O14523
SHGNSIFRIDTEGTN	EGF	51	P01133
LGSSLGSLDQHQGSQ	CACNA1S	1851	Q13698
GNDNIHALTAQGTSE	FCN2	176	Q15485
FAEEVLISGHSQGNS	FRMPD1	161	Q5SYB0
LLVLGNNHSSGSETA	COL6A5	2551	A8TX70
ADLSGISNHSNIQVS	SERPINA5	331	P05154
QGSGHENSLELDSSI	CEP250	361	Q9BV73
LDAQHESGQSSSRGS	BNIP3L	76	O60238
TANSDTHLLQGQSLT	CD4	126	P01730
SVELGLDNGHSAIQT	AKAP5	211	P24588
QTLGNHSRGEQDSSL	CEP85L	131	Q5SZL2
LEQASSHIGNSTQAT	ATL3	511	Q6DD88
NGTHLDAGALTTTFE	CASP8	261	Q14790
SQAGTVLDSNHTVGV	IDUA	406	P35475
QALDSGQGAALTTAT	GP1BA	561	P07359
GQGAALTTATQTTHL	GP1BA	566	P07359
NIDAHNTSVALGDTS	CEP192	536	Q8TEP8
GISAESLHGNSEQSD	DDX53	491	Q86TM3
QGLNTHGASEISEDQ	HRH1	336	P35367
REGGISSDSSHQKEQ	CCDC168	1651	Q8NDH2
VVGGSHQNAISSDKT	FAM135B	596	Q49AJ0
NHITLENISSGSSLN	CRB1	651	P82279
STDTGEHLGLQFQQS	CSRP3	81	P50461
GAVAENDSVTLQHLS	HELZ2	1956	Q9BYK8
LVASVSESGLQAQHG	GPRIN2	261	O60269
ISLHEDNSNSESLTG	FDXACB1	291	Q9BRP7
GSEDSQGSEHLLNGQ	CA10	136	Q9NS85
QLSRSQHSASEEGGN	C4orf54	251	D6RIA3
AHSFATENIIGGSEQ	CEP295	2156	Q9C0D2
GATETASQGHLDLTQ	COL15A1	31	P39059
GVVNDIGNHLFSTIS	DNAH2	891	Q9P225
SSDAQGSGDATVHQR	EPB41L4A	631	Q9HCS5
QTTNVSDLGLEHSDS	PKNOX2	456	Q96KN3
SGHLVTLAGDVTNQF	PKD1L1	2576	Q8TDX9
LASLNTGDNESVHSG	CAMSAP2	1291	Q08AD1
QAADLQGEGLSTTAT	CDH1	346	P12830
TVAHADTGIQTNGDL	FAM153B	176	P0C7A2
AATVAAGLDGLHSSN	LGSN	421	Q5TDP6
FTEIGAGSQQLDSIH	MAP4K5	716	Q9Y4K4
NTDDNIGGAHFTETL	HSPA14	221	Q0VDF9
EGGSFNLSSNELHVT	FREM3	841	P0C091
THIDAGITDNSAGTL	RIMBP2	271	O15034
SSGVLEINSSVHQNA	PRUNE2	1851	Q8WUY3
TGGSQLHSENSVIGQ	SH2D2A	336	Q9NP31
HGGLSSDAQESLEVA	SGTA	21	O43765
AVGLSGDHSALESQI	SYNE1	8321	Q8NF91
VANHVASDISLTGGS	SEL1L	321	Q9UBV2
EDNTSSLTHGAGQVL	LRRC56	316	Q8IYG6
NNGQSLESSSLEGSH	NXN	181	Q6DKJ4
GTSQVHSECGLILNT	NXPE4	211	Q6UWF7
NINEHTGSISSELES	PROM1	586	O43490
NANLSSENISGSGLH	SIX4	591	Q9UIU6
GTVHGNANSVALTQE	RXFP2	91	Q8WXD0
QGLVIGQLSSHFSEE	SLC22A18	291	Q96BI1
HLAQQTAELDSSLGT	SPTBN5	591	Q9NRC6
LLNSLTGTNHSIGSA	AAGAB	186	Q6PD74
NLVSAAGGSISHQVS	SLC25A12	201	O75746
HSKGSEQTTGAENEV	CLSPN	361	Q9HAW4
SQGLHSQGSLSDAIS	SS18L1	96	O75177
SLQSGNVSAVDLTNH	COL24A1	316	Q17RW2
VSLEDHSSQGTLVNN	TCF19	71	Q9Y242
TAQGNTEVIHTGTLQ	ZNF845	61	Q96IR2
TAQGNTEVIHTGTLQ	ZNF525	61	Q8N782
ESQAAHLLSLEGQTG	ZNF767P	26	Q75MW2
SSAGDTSAAHQVVLG	RNF214	76	Q8ND24
TSGGTESNNLVIHSV	SCLY	96	Q96I15
AAGNHGSQKETDLIT	ZXDB	781	P98169
GADEGTELASNTHNI	UBAP2	221	Q5T6F2
NTLSSTGQGNTEVIH	ZNF320	56	A2RRD8
SHIGDLQKADTSSQG	NUFIP2	596	Q7Z417
QLSGDSTLNTNDLTH	SP3	561	Q02447
ASVGEQGEGSTILQH	STAT6	66	P42226
NDGLSSLFSVVEHSG	SOGA1	1251	O94964
AGDSSSHRQQGITDE	SPAG1	606	Q07617
QEAILHASGNGTTKD	SPPL2A	26	Q8TCT8
GNVSQHLDFGSSLEQ	ZNF620	121	Q6ZNG0
ASLQATDSQGNTVLH	TRPV2	236	Q9Y5S1
IESLHSENSGKSGQE	USP25	346	Q9UHP3
AGHQIASETQILEGS	TTC3	1396	P53804
LHTNVNDGTEFGGSI	VDAC2	191	P45880
ISQGHQAFLLEGDSS	VWA5A	91	O00534
TQHNGDAAASLTVAE	STOML2	266	Q9UJZ1
TEGSATHATQLLVLG	IGSF9	211	Q9P2J2
EAIGAAVLSQGESSH	SEC16B	651	Q96JE7
FEISNGSHELLSQGQ	ZNF839	756	A8K0R7
ENGVNGTLTSNVADS	TRAM1	351	Q15629
ENHSSLVSLGGEIQT	ZKSCAN4	251	Q969J2
AHGLSSSLQSNELVD	ZCCHC7	116	Q8N3Z6
ISTEALVNGHANSAV	USP10	171	Q14694
STGQGNTEVIHTGTL	ZNF611	76	Q8N823
EEHQNLSTNSETLGI	TSPEAR	316	Q8WU66
LSGGEASSQSTHELQ	PLEKHG1	721	Q9ULL1
SSLADGGLAHNLQDS	TEX28	36	O15482
TEDGQVIATSQSGAH	ZNF407	1906	Q9C0G0
SLSSVEQLDQVHGSN	WIPI1	41	Q5MNZ9
VTSGSGHRLNITAEN	XPO6	531	Q96QU8
DGQAQEILAHNTSSI	TGM7	411	Q96PF1
EGAASVSELHLTANQ	SLIT1	586	O75093
LSTGQGNTEVIHTGT	ZNF600	6	Q6ZNG1
QSHQEKTTDSGLTEG	UIMC1	141	Q96RL1
SANESHVLGTGQSLD	HIVEP1	906	P15822
ISISHDNTSALELQG	SIGLEC11	256	Q96RL6
FTGDSDLQQQALHSG	ZNF17	156	P17021
DVGLGLNSSSLSNSH	TBPL2	141	Q6SJ96
SSNNRLVVTGSGEHA	TLE6	551	Q9H808
HSDLQGLVQGSDSEA	ZBTB34	331	Q8NCN2
HTADTSQNIELGVSL	VPS13D	3216	Q5THJ4
NHSEGGGVIVNNTES	WBP2	6	Q969T9
GTQSLHTNSFDEALG	MMUT	381	P22033